217 related articles for article (PubMed ID: 18378794)
1. 12(S)-Hydroxyheptadeca-5Z, 8E, 10E-trienoic acid is a natural ligand for leukotriene B4 receptor 2.
Okuno T; Iizuka Y; Okazaki H; Yokomizo T; Taguchi R; Shimizu T
J Exp Med; 2008 Apr; 205(4):759-66. PubMed ID: 18378794
[TBL] [Abstract][Full Text] [Related]
2. Metabolism and biological functions of 12(S)-hydroxyheptadeca-5Z,8E,10E-trienoic acid.
Okuno T; Yokomizo T
Prostaglandins Other Lipid Mediat; 2021 Feb; 152():106502. PubMed ID: 33075476
[TBL] [Abstract][Full Text] [Related]
3. Thromboxane A synthase-independent production of 12-hydroxyheptadecatrienoic acid, a BLT2 ligand.
Matsunobu T; Okuno T; Yokoyama C; Yokomizo T
J Lipid Res; 2013 Nov; 54(11):2979-87. PubMed ID: 24009185
[TBL] [Abstract][Full Text] [Related]
4. 12(S)-hydroxyheptadeca-5Z,8E,10E-trienoic acid (12-HHT) induces cell growth and improves barrier function through BLT2 interaction in intestinal epithelial Caco-2 cell cultures.
Storniolo CE; Pequera M; Company F; Moreno JJ
Biochem Pharmacol; 2021 Aug; 190():114663. PubMed ID: 34161796
[TBL] [Abstract][Full Text] [Related]
5. 12-Hydroxyheptadecatrienoic acid promotes epidermal wound healing by accelerating keratinocyte migration via the BLT2 receptor.
Liu M; Saeki K; Matsunobu T; Okuno T; Koga T; Sugimoto Y; Yokoyama C; Nakamizo S; Kabashima K; Narumiya S; Shimizu T; Yokomizo T
J Exp Med; 2014 Jun; 211(6):1063-78. PubMed ID: 24821912
[TBL] [Abstract][Full Text] [Related]
6. Development and Characterization of a Fluorescent Ligand for Leukotriene B4 Receptor 2 in Cells and Tissues.
Heering J; Hernandez-Olmos V; Ildefeld N; Liu T; Kaiser A; Naeem Z; Frömel T; Fleming I; Steinhilber D; Proschak E
J Med Chem; 2022 Feb; 65(3):2023-2034. PubMed ID: 34995452
[TBL] [Abstract][Full Text] [Related]
7. The leukotriene B4 receptor BLT2 protects barrier function via actin polymerization with phosphorylation of myosin phosphatase target subunit 1 in human keratinocytes.
Chiba T; Nakahara T; Hashimoto-Hachiya A; Yokomizo T; Uchi H; Furue M
Exp Dermatol; 2016 Jul; 25(7):532-6. PubMed ID: 26896822
[TBL] [Abstract][Full Text] [Related]
8. Leukotriene B4 receptor type 2 (BLT2) enhances skin barrier function by regulating tight junction proteins.
Ishii Y; Saeki K; Liu M; Sasaki F; Koga T; Kitajima K; Meno C; Okuno T; Yokomizo T
FASEB J; 2016 Feb; 30(2):933-47. PubMed ID: 26527063
[TBL] [Abstract][Full Text] [Related]
9. Leukotriene B4 receptor BLT2 negatively regulates allergic airway eosinophilia.
Matsunaga Y; Fukuyama S; Okuno T; Sasaki F; Matsunobu T; Asai Y; Matsumoto K; Saeki K; Oike M; Sadamura Y; Machida K; Nakanishi Y; Kubo M; Yokomizo T; Inoue H
FASEB J; 2013 Aug; 27(8):3306-14. PubMed ID: 23603839
[TBL] [Abstract][Full Text] [Related]
10. Identification, signaling, and functions of LTB
Saeki K; Yokomizo T
Semin Immunol; 2017 Oct; 33():30-36. PubMed ID: 29042026
[TBL] [Abstract][Full Text] [Related]
11. Nonredundant roles for leukotriene B4 receptors BLT1 and BLT2 in inflammatory arthritis.
Mathis SP; Jala VR; Lee DM; Haribabu B
J Immunol; 2010 Sep; 185(5):3049-56. PubMed ID: 20656922
[TBL] [Abstract][Full Text] [Related]
12. A turn on and a turn off: BLT1 and BLT2 mechanisms in the lung.
Watanabe M; Machida K; Inoue H
Expert Rev Respir Med; 2014 Aug; 8(4):381-3. PubMed ID: 24742066
[TBL] [Abstract][Full Text] [Related]
13. Protective role of the leukotriene B4 receptor BLT2 in murine inflammatory colitis.
Iizuka Y; Okuno T; Saeki K; Uozaki H; Okada S; Misaka T; Sato T; Toh H; Fukayama M; Takeda N; Kita Y; Shimizu T; Nakamura M; Yokomizo T
FASEB J; 2010 Dec; 24(12):4678-90. PubMed ID: 20667973
[TBL] [Abstract][Full Text] [Related]
14. Non-steroidal anti-inflammatory drug delays corneal wound healing by reducing production of 12-hydroxyheptadecatrienoic acid, a ligand for leukotriene B
Iwamoto S; Koga T; Ohba M; Okuno T; Koike M; Murakami A; Matsuda A; Yokomizo T
Sci Rep; 2017 Oct; 7(1):13267. PubMed ID: 29038497
[TBL] [Abstract][Full Text] [Related]
15. 12(S)-Hydroxyheptadeca-5Z,8E,10E-trienoic acid suppresses UV-induced IL-6 synthesis in keratinocytes, exerting an anti-inflammatory activity.
Lee JW; Ryu HC; Ng YC; Kim C; Wei JD; Sabaratnam V; Kim JH
Exp Mol Med; 2012 Jun; 44(6):378-86. PubMed ID: 22391335
[TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of bioactive metabolites of 12-hydroxyheptadecatrienoic acid, a ligand for leukotriene B4 receptor 2.
Yasukawa K; Okuno T; Ogawa N; Kobayashi Y; Yokomizo T
J Biochem; 2023 Mar; 173(4):293-305. PubMed ID: 36539331
[TBL] [Abstract][Full Text] [Related]
17. Structure of the agonist 12-HHT in its BLT2 receptor-bound state.
Giusti F; Casiraghi M; Point E; Damian M; Rieger J; Bon CL; Pozza A; Moncoq K; Banères JL; Catoire LJ
Sci Rep; 2020 Feb; 10(1):2630. PubMed ID: 32060341
[TBL] [Abstract][Full Text] [Related]
18. Two distinct leukotriene B4 receptors, BLT1 and BLT2.
Yokomizo T
J Biochem; 2015 Feb; 157(2):65-71. PubMed ID: 25480980
[TBL] [Abstract][Full Text] [Related]
19. Leukotriene B4 receptor 2 regulates the proliferation, migration, and barrier integrity of bronchial epithelial cells.
Liu M; Shen J; Yuan H; Chen F; Song H; Qin H; Li Y; Xu J; Ye Q; Li S; Saeki K; Yokomizo T
J Cell Physiol; 2018 Aug; 233(8):6117-6124. PubMed ID: 29323699
[TBL] [Abstract][Full Text] [Related]
20. Biological functions of 12(
Okuno T; Yokomizo T
Inflamm Regen; 2018; 38():29. PubMed ID: 30397418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
